Summary
Glucose loading is known to cause acute suppression of plasma aldosterone and stimulation of plasma renin activity. The relative contribution of variations in circulating angiotensin II to the regulation of aldosterone secretion following glucose loading was assessed in ten normal subjects. The effects of a standard oral glucose loading test (100 g) on plasma concentrations of glucose, insulin, potassium, aldosterone, renin activity and cortisol were studied (a) under basal conditions, and (b) after inhibition of angiotensin II with the converting enzyme inhibitor captopril (50 mg t.i.d. during 3 days). Under basal conditions the acute increase in plasma glucose and insulin after glucose loading was accompanied by a significant decrease (P<0.01) in plasma cortisol and aldosterone and by a significant increase in plasma renin activity (P<0.01); plasma potassium was decreased slightly but not significantly. Following captopril treatment preloading plasma renin activity was increased significantly, most probably reflecting an effective reduction of angiotensin II. Glucose loading caused a similar suppression of plasma aldosterone, as observed under basal conditions. This observation suggests that renin activation does not substantially contribute to the acute regulation of plasma aldosterone after an oral glucose load.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atkinson AB, Brown JJ, Davies DL, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JIS (1979) Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet II:606–609
Atkinson AB, Brown JJ, Lever AF, Robertson JIS (1980) Combined treatment of severe intractable hypertension with captopril and diuretic. Lancet II:105–108
Beretta-Piccoli C, Weidmann P, Flammer J, Glück Z, Bachmann C (1980) Effects of standard oral glucose loading on the renin-angiotensin-aldosterone system and its relationship to circulating insulin. Klin Wochenschr 58:467–474
Beretta-Piccoli C, Weidmann P, Meier A, Grimm M, Keusch G, Glück Z (1980) Effects of short-term norepinephrine infusion on plasma catecholamines, renin and aldosterone in normal and hypertensive man. Hypertension 2:623–630
Beretta-Piccoli C, Weidmann P, Brown JJ, Fraser R, Lever AF, Marone C, Robertson JIS (1982) Effects of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism. Acta Endocrinol (Kbh) 101:66–71
Bravo EL, Tarazi RC (1979) Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension 1:39–46
Brunner HR, Gavras H, Waeber B, Kerhaw GR, Turini GA, Vukovich RA, Mckinstry DN (1979) Oral angiotensinconverting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med 90:19–23
Cannon PJ, Ames RP, Laragh JH (1966) Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease. J Clin Invest 45:865–879
Cooke CR, Horwath HS, Moore MA, Bledsoe T, Walker WG (1973) Modulation of plasma aldosterone concentration by plasma potassium in anephric man in the absence of a change in potassium balance. J Clin Invest 52:3028–3032
Davis JO, Urqhart J, Higgins JT Jr (1963) The effects of alterations in plasma sodium and potassium concentration on aldosterone secretion. J Clin Invest 42:597–609
De Fronzo R, Sherwin RS, Dilligham M, Hendler R, Tamborlane WV, Felig P (1978) Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. J Clin Invest 61:472–479
De Fronzo R, Lee R, Jones A, Bia M (1980) Effect of insulopenia and adrenal hormone deficiency on acute potassium tolerance. Kidney Int 17:586–594
Dluhy RG, Axelrod L, Underwood RH, Williams GH (1971) Studies on the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion. J Clin Invest 51:1950–1957
Ferguson RK, Brunner HR, Turini GA, Gavras H, McKinstry DN (1977) A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet I:775–778
Ferrier CP, Bianchetti MG, Beretta-Piccoli C, Link L, Bachmann C, Weidmann P (1983) Studies on acute glucose-induced aldosterone suppression. Role of corticotropin. Acta Endocrinol (Kbh) 103:391–399
Fraser R, Brown JJ, Lever AF, Mason PA, Robertson JIS (1979) Control of aldosterone secretion. Clin Sci 56:389–399
Hales CN, Randle PJ (1963) Immunoassay of insulin with insulin antibody precipitation. Biochem J 88:137–146
Hiatt N, Yamakawa T, Davidson MB (1974) Necessity for insulin in transfer of excess infused K to intracellular fluid. Metabolism 23:43–49
Himathongkam T, Dluhy RG, Williams GH (1975) Potassium-aldosterone-renin interrelationship. J Clin Endocrinol Metab 41:153–159
Malvano R, Gandolfi C, Gianessi D, Gianotti P, Grosso P (1976) Radioimmunoassay of aldosterone in crude plasma extracts. J Nucl Biol Med 20:37–44
Mersey JH, Williams GH, Hollenberg NK, Dluhy RG (1977) Relationship between aldosterone and bradykinin. Circ Res 40 (suppl I):71–84
Müller J (1970) Steroidogenic effect of stimulators of aldosterone biosynthesis upon separate zones of the rat adrenal cortex: Influence of sodium and potassium defiency. Eur J Clin Invest 1:180–187
Murphy BP, Engelberg W, Pattee CJ (1963) Simple method for the determination of plasma corticoids. J Clin Endocrinol Metab 23:293–300
Oelkers W, Brown JJ, Fraser R, Lever AF, Morton JJ, Robertson JIS (1974) Sensitisation of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res 34:69–77
Ølgaard K (1975) Plasma aldosterone in anephric and non-nephrectomized dialysis patients in relation to changes in plasma potassium without change in total potassium balance. Acta Med Scand 198:213–218
Saruta T, Cook R, Kaplan NM (1972) Adrenocortical steroidogenesis: studies on the mechanism of action of angiotensin and electrolytes. J Clin Invest 71:2239–2245
Sealey JE, Gertens-Banes J, Laragh JH (1972) The reninsystem: Variations in man measured by radioimmunoassay or bioassay. Kidney Int 1:240–253
Veyrat R, Brunner HR, Manning EL, Müller AF (1966) Inhibition de l'activité de la rénine plasmatique par le potassium. J Urol Nephrol 73:271–275
Young JB, Rowe JW, Pallotta JA, Sparrow E, Landsberg L (1980) Enhanced plasma norepinephrine response to upright posture and oral glucose administration in elderly human subjects. Metabolism 29:532–539
Weidmann P, Horton R, Maxwell MH, Franklin SS, Fichmann M (1973) dynamic studies of aldosterone in anephric man. Kidney Int 4:289–298
Weidmann P, Maxwell MH, De Lima J, Hirsch D, Franklin SS (1975) Control of aldosterone responsiveness in terminal renal failure. Kidney Int 7:351–359
Weidmann P, Beretta-Piccoli C, Ziegler WH, Keusch G, Glück Z, Reubi FC (1978) Age versus urinary sodium for judging subjects and patients with essential hypertension. Kidney Int 14:619–628
Williams GH, Hollenberg NK (1977) Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med 297:184–188
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nützi, D., Beretta-Piccoli, C., Ferrier, C.P. et al. Studies on acute glucose-induced aldosterone suppression: Role of renin-angiotensin system. Klin Wochenschr 62, 213–217 (1984). https://doi.org/10.1007/BF01721046
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01721046